CFF CIO Alert: Fuel Your Pipeline
Adela Skenderasi named CIO at Cystic Fibrosis Foundation. Pitch endowment management & predictive analytics. Secure deal flow and boost commission.
Published on
Do not index
Do not index
๐ Battle Card: Cystic Fibrosis Foundation
Quick trigger:
ย
๐ค Decision Maker in the News
- Adela Skenderasi, Chief Investment Officer ยท ๐ [LinkedIn](https://www.linkedin.com/company/cystic-fibrosis-foundation/)
ย
๐ก Why It Matters
- Sheโll overhaul the Foundationโs endowment and venture-philanthropy model to secure sustainable funding for breakthrough CF therapies. โ Source
ย
๐ฏ Core Pain Point
- Ensuring consistent, long-term funding to support high-cost research and trials
- Aligning portfolio strategy with mission-driven outcomes
ย
๐ฐ What to Pitch
- Primary: Endowment management platform โ Optimize asset allocation & risk controls
- Expansion: Predictive analytics & reporting โ Drive higher ROI and mission alignment
ย
๐บ๏ธ Quick Context
- HQ: Bethesda, MD
- Employees: โ 300
- Rev: โ $200 M
- Website: [cff.org](https://www.cff.org/)
ย
(Heads up: this is a Cystic Fibrosis Foundation sales triggerโdonโt let it slip!)
ย
๐คผ Competitive Intel
*Which other vendors youโll probably face to win Cystic Fibrosis Foundationโs business.*
ย
- BlackRock Aladdin โ Endowment & Risk Management
- Unique edge: Institutional-grade portfolio analytics
- Evaluated by CIO for global multi-asset capabilities
- Bloomberg AIM โ Asset & Investment Management
- Unique edge: Real-time market data integration
- Evaluated by Finance for trading and compliance
- FactSet โ Portfolio Analytics & Research
- Unique edge: Deep multi-asset class research tools
- Evaluated by Investment Team for custom modeling
- Workday Adaptive Planning โ FP&A & Forecasting
- Unique edge: Seamless budgeting with HR headcount planning
- Evaluated by CFO for financial consolidation
- Salesforce Financial Services Cloud โ Foundation CRM
- Unique edge: Donor engagement & grant tracking
- Evaluated by Director of Development for fundraising sync
ย
(This is another Cystic Fibrosis Foundation sales triggerโget ahead of the pack.)
ย
โ Do-Now Checklist
Connect with Adela Skenderasi on LinkedIn (link above)
Customize first-touch email highlighting investment portfolio ROI gains
Log follow-up tasks in CRM (Day 3 & Day 10)
ย
Next Step
Donโt miss out on any Cystic Fibrosis Foundation sales triggerโget intel like this daily.
Subscribe to NewsletterForLeads
ย
๐ง Copy My Prompt for Personalized Cold Outreach
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
โ๏ธ YOUR COMPANY
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
OUR_COMPANY = โโ
OFFER_BRIEF = โEndowment management platform for nonprofit fundsโ
PROOF_METRIC = โ15% ROI boost in 6 monthsโ
CTA_STYLE = โquick_callโ
TONE = โfriendlyโ
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
๐ TARGET COMPANY
โโโโโโโโโโโโโโโโโโโโโโโโโโโโ
NAME = Adela
COMPANY = Cystic Fibrosis Foundation
DEPT = Investment
SIZE = โ TBD
BOTTLENECK = Ensuring consistent, long-term funding slows growth.
EVENT = Announces Adela Skenderasi as next Chief Investment Officer
DETAIL = Cystic Fibrosis Foundation Announces Adela Skenderasi as Next Chief Investment Officer
PAIN = Ensuring consistent, long-term funding for high-cost research
SRC = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250924109535&div=41152219
SIM_CO = Bill & Melinda Gates Foundation
WIN_METRIC = 15% higher ROI on endowment
NEXT_SIZE = โ TBD
EMP_EST = โ 300
REV_EST = โ $200M
โโโโโโโโโโโโโโโโโโโโโโโโ
TASK FOR CHATGPT
โโโโโโโโโโโโโโโโโโโโโโโโ
Role: โNewsletterForLeads SDR-Assistโ.
Validate any โ guesses via SRC.
EMAIL (keep breaks):
Subject: โ TBD-person Investment
Adelaโnoticed your Investment team is โ TBD.
Thatโs when Ensuring consistent, long-term funding slows growth.
We helped Bill & Melinda Gates Foundation fix this with Endowment management platform for nonprofit funds.
Result: 15% higher ROI on endowment.
Quick call?
PSโnext bottleneck hits โ TBD.
DM โค45 words, TONE:
Saw your post about Cystic Fibrosis Foundation Announces Adela Skenderasi as Next Chief Investment Officer โ Ensuring consistent, long-term funding for high-cost research.
Endowment management platform for nonprofit funds. 15% ROI boost in 6 months.
Quick chat?